Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a clinical form of Chagas Disease.
Oliveira Junior. Luiz Roberto de LR; Carvalho. Thaysa Buss TB; Santos. Rodrigo Mattos Dos RMD; Costa. Érika Alessandra Pellison Nunes da ÉAPND; Pereira. Paulo Câmara Marques PCM; Kurokawa. Cilmery Suemi CS
Key Findings
- Patients with the cardiac form of Chagas disease had significantly lower serum 25(OH)D3 (vitamin D) levels than those with the indeterminate form.
- LL‑37 peptide levels did not differ between cardiac and indeterminate groups.
- VDR gene polymorphisms (FokI, BsmI, ApaI, TaqI) showed no significant association with vitamin D levels or disease form.
Practical Outcomes
- For biohackers, the main takeaway is that maintaining adequate vitamin D status might be especially important for heart health in chronic Chagas patients, though the study does not prove that supplementation will prevent cardiac complications. Monitoring vitamin D levels and correcting deficiencies could be a reasonable precaution, but there is no direct evidence to change LL‑37 or VDR‑targeted protocols based on this work.
Summary
In people with chronic Chagas disease, those who have heart problems tend to have lower blood levels of vitamin D, but their levels of the antimicrobial peptide LL‑37 are similar to those without heart issues. The study didn't find any link between common vitamin D‑receptor gene variants and disease form.
Abstract
Chagas disease (CD) is an important public health problem in Brazil and worldwide. Aging and obesity are important matters in patients with CD, as is hypovitaminosis D3, which can decrease the quality of life of these patients. Immunomodulation mediated by vitamin D3, especially the production of antimicrobial peptides such as cathelicidin LL-37, might be related to the severity and symptoms of CD. This study aimed to determine the serum levels of vitamin D and LL-37 and VDR gene polymorphisms in patients with chronic CD. This study included male patients with cardiac and indeterminate clinical forms of CD. Clinical, anthropometric, and blood parameters were obtained. Serum levels of 25(OH)D3 and LL-37 were determined by chemiluminescence and enzyme-linked immunosorbent assay respectively. Fok (rs731236), Bsm (rs1544410), Apa (rs7975232), and Taq (rs731236) polymorphisms of the VDR gene were investigated by PCR-RFLP. Sixty-four patients were included in the study: 18 of the cardiac form and 46 of the indeterminate form. No differences in age, ethnicity, BMI, arterial hypertension, diabetes mellitus, or dyslipidemias were observed between groups. However, the serum levels of 25(OH)D3, but not of LL-37, were lower in the cardiac form group. The association among polymorphisms, vitamin D, and clinical form was not significant. Decreased levels of vitamin D suggest an association with the cardiac form of CD. Studies investigating the roles of vitamin D and LL-37 in the immune response and their associations with VDR polymorphisms and disease susceptibility are necessary.
Study Information
pubmed
2019
2019-09-05T00:00:00.000Z
10.1590/0037-8682-0133-2019
8
66